###begin article-title 0
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes
###end article-title 0
###begin p 1
These two authors contributed equally to the work.
###end p 1
###begin p 2
Supplementary note online.
###end p 2
###begin p 3
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 3
###begin p 4
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 655 657 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 706 712 706 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 779 780 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 791 793 791 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 825 826 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 837 839 837 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
The concept of susceptibility genes common to different autoimmune diseases is now firmly established with previous studies demonstrating overlap of loci conferring susceptibility to type 1 diabetes (T1D) with both Coeliac disease and multiple sclerosis. Rheumatoid arthritis (RA) is an archetypal autoimmune disease and we, therefore, targeted putative T1D susceptibility loci for genotyping in UK RA cases and unrelated controls. A novel RA susceptibility locus at AFF3 was identified with convincing evidence for association in a combined sample cohort of 6819 RA cases and 12 650 controls [OR 1.12 95% confidence intervals (CI) 1.07-1.17, P = 2.8 x 10-7]. Association of two previously described loci (CTLA-4 and 4q27) with RA was also replicated (OR 0.87, 95% CI 0.82-0.94, P = 1.1 x 10-4 and OR 0.86, 95% CI 0.79-0.94, P = 5.4 x 10-4, respectively). These findings take the number of established RA susceptibility loci to 13, only one of which has not been associated with other autoimmune diseases.
###end p 4
###begin title 5
INTRODUCTION
###end title 5
###begin p 6
###xml 765 766 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C1">1</xref>
###xml 767 768 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C6">6</xref>
###xml 956 957 956 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C7">7</xref>
###xml 1034 1040 1034 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 1047 1059 1047 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22*R620W</italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 1189 1190 1189 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C1">1</xref>
###xml 1191 1192 1191 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C8">8</xref>
Rheumatoid arthritis (RA) is a disease in which uncontrolled inflammation of synovial joints may cause progressive joint damage and consequent long-term disability. It is a typical autoimmune disease, being characterized by the elaboration of auto-antibodies to immunoglobulins (rheumatoid factor) and cyclic citrullinated peptides (anti-CCP antibodies) and by genetic associations with the class II region of the major histocompatibility complex. Genome wide association (GWA) and subsequent validation studies have successfully identified a number of novel RA susceptibility loci but it is already clear that simply following up the top tiers of significantly associated markers from such studies is unlikely to identify all the relevant disease-associated loci (1-6). Clustering of autoimmune diseases, including type 1 diabetes (T1D) and RA, is apparent in families and it has already been established that RA and T1D share common susceptibility loci (7). For example, a non-synonymous single nucleotide polymorphism (SNP) in the PTPN22 gene (PTPN22*R620W) has been associated with susceptibility to both diseases as has polymorphism at the interleukin 2 receptor alpha (IL2RA) locus (1,8). Given that T1D is an autoimmune disease for which a large number of susceptibility variants have already been identified, we sought to explore the hypothesis that putative T1D susceptibility genes/loci are also associated with RA.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin p 8
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C8">8</xref>
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 202 209 202 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLEC2D2</italic>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C2">2</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C8">8</xref>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C9">9</xref>
###xml 565 566 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 793 794 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C8">8</xref>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C9">9</xref>
T1D putative genetic susceptibility loci were selected for investigation from information available from a previous study (8), excluding markers mapping to the INS (not a strong candidate gene for RA), CLEC2D2 (associated by multi-locus imputation analysis only) and PTPN22 (RA data published previously) (2) genes (8,9). Eighteen single nucleotide polymorphisms (SNPs) mapping to 14 distinct loci were genotyped in 3962 UK RA cases and 3531 unrelated UK controls. A Bonferroni correction of 14 was applied to correct for the number of loci studied, resulting in a P-value threshold of 0.004 for claims of significance. The sample size had >80% power to identify association at this threshold assuming the same effect sizes as reported previously for T1D for most of the loci investigated () (8,9).
###end p 8
###begin p 9
###xml 60 71 60 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3, CTLA4</italic>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2/21</italic>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP177TB1">1</xref>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 204 206 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 669 671 669 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C1">1</xref>
###xml 890 891 890 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C8">8</xref>
###xml 1073 1074 1073 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1255 1256 1255 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1267 1269 1267 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
Of the 18 SNPs tested, four variants mapping to three loci (AFF3, CTLA4 and IL2/21) showed evidence for association with RA (Table 1). These included two SNPs [rs10865035 OR 1.13 (1.06-1.21), P = 4.0 x 10-4 and rs1160542 OR 1.12 (1.05-1.20), P = 0.001] mapping to the AFF3 locus, which are highly correlated (r2 = 0.97) with each other. Conditional logistic regression analysis suggested that the primary effect is from rs10865035. A perfect proxy for this variant was genotyped as part of the Wellcome Trust Case Control Consortium (WTCCC) study (rs9653442) and also showed evidence for association in that cohort of 1860 RA cases and 2920 controls (trend P = 4.8 x 10-4) (1). For the rs10865035 SNP, data was available from an additional cohort of 997 RA cases, recruited as part of an inception cohort study of RA outcome and 6199 controls with published genotype frequencies available (8). In total, therefore, data was available for 6819 RA cases and 12 650 controls. Allele frequencies were similar across the three control cohorts with no evidence of heterogeneity (P = 0.39). Hence, a combined analysis across all samples was undertaken and confirmed strong evidence for association of this locus with RA susceptibility (OR 1.12 95% CI 1.07-1.17, P = 2.8 x 10-7).
###end p 9
###begin p 10
T1D-associated SNPs tested for association with RA
###end p 10
###begin p 11
The gene name refers to the nearest gene in the region although SNPs are not necessarily intra-genic.
###end p 11
###begin p 12
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Chr, chromosome; HWE, P-value statistic for Hardy-Weinberg equilibrium test; MAF, minor allele frequency; OR, odds ratio (95% confidence intervals).
###end p 12
###begin p 13
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C10">10</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C11">11</xref>
###xml 544 545 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 556 558 556 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP177F1">1</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C11">11</xref>
A variant mapping to the CTLA-4 gene showed the strongest evidence for association with RA in the current cohort (rs3087243 OR 0.87, 95% CI 0.82-0.94, P = 1.1 x 10-4). There have been previous reports of association of this variant with RA but findings have been inconsistent, probably reflecting the modest sample sizes used in many of the previous investigations (10,11). Combining the results from two previous well-powered studies with the current data, the SNP is confirmed as being associated with RA susceptibility [OR 0.88 (0.83-0.93), P = 2.6 x 10-6] (Fig. 1) (11).
###end p 13
###begin p 14
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
Meta-analysis of current data for the rs3087243 SNP in the CTLA-4 gene with data from a previous study in two well-powered cohorts of RA patients and controls.
###end p 14
###begin p 15
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2-IL21</italic>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C9">9</xref>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
A SNP mapping within the IL2-IL21 locus on chromosome 4q27, previously reported to be associated with T1D, Coeliac disease and RA, was also associated with RA susceptibility in the current series (9). As reported previously, it was the common allele that predisposed to disease [rs6822844 OR 0.86, (0.79-0.94), P = 5.4 x 10-4].
###end p 15
###begin p 16
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP177TB2">2</xref>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
The three loci show evidence for association with T1D and RA and are strong candidates for pan-autoimmunity susceptibility genes. If these loci predispose to autoimmunity in general, it might be expected that associations would be stronger in subsets of patients with auto-antibodies. However, following stratification by presence of auto-antibodies, the strength of associations was similar between auto-antibody positive and negative individuals at all three SNPs indicated by the overlapping confidence intervals (Table 2).
###end p 16
###begin p 17
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Results for SNPs with evidence for association with T1D and RA after stratifying by auto-antibody status in RA patients
###end p 17
###begin p 18
RF, rheumatoid factor; CCP, anti-cyclic citrullinated peptide antibody; Pos, positive; Neg, negative.
###end p 18
###begin p 19
###xml 10 18 <span type="species:ncbi:9606">patients</span>
Number of patients for whom auto-antibody data available: RF pos=2470; RF neg=934; Anti-CCP pos=1446; Anti-CCP neg=674; CCP neg+RF neg (auto-antibody negative)=400; CCP pos +/or RF pos (auto-antibody positive)=2958.
###end p 19
###begin p 20
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aOR (95% CI)=odds ratio and 95% confidence intervals.
###end p 20
###begin p 21
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7R</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C8">8</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C12">12</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C13">13</xref>
Finally, although the common allele of a non-synonymous SNP (rs6897932) mapping to the IL7R gene previously associated with both T1D and multiple sclerosis was somewhat over-represented in RA cases (OR 0.90, 95% CI 0.84-0.97; trend P = 0.007), this did not achieve statistical significance at the corrected P-value threshold (8,12,13).
###end p 21
###begin title 22
DISCUSSION
###end title 22
###begin p 23
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C14">14</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C15">15</xref>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2-IL21</italic>
The concept of pan-autoimmunity susceptibility genes is now firmly established with recent reports of overlap between T1D and Coeliac disease as well as T1D and multiple sclerosis (14,15). By targeting variants with suggestive evidence for association with T1D, we have identified a novel association of the AFF3 locus with RA susceptibility. In addition, association of two other loci, the CTLA4 and IL2-IL21 regions, has also been confirmed.
###end p 23
###begin p 24
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C8">8</xref>
###xml 590 591 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 600 602 600 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C16">16</xref>
###xml 460 468 <span type="species:ncbi:9606">patients</span>
The association of variants in the AFF3 locus with susceptibility to RA has not previously been described. The variant was selected for genotyping because there was suggestive evidence for association with T1D in one large case-control series (P = 5.0 x10-6), although this was not subsequently replicated in a smaller family-based study (8). However, we have found evidence for association of the variant in three independent case-control series including UK patients with RA and controls with combined analysis reaching a threshold that some regard as achieving genome-wide significance (P < 5 x 10-7). The associated variants map to the 5' and promoter region of the AFF3 gene, which is strongly conserved in evolution and is preferentially expressed in lymphoid cells (16). It encodes a nuclear factor that can interact with DNA and contains transcriptional activation domains, making it a strong candidate autoimmunity gene.
###end p 24
###begin p 25
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C17">17</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C18">18</xref>
###xml 676 684 <span type="species:ncbi:9606">patients</span>
Our findings also support association of the CTLA4 gene with RA susceptibility. CTLA4 is a co-stimulatory receptor expressed on activated T cells which down-regulates the T cell response. The rs3087243 SNP maps within the 3' region of the CTLA-4 gene and previous functional studies have identified a correlation between the ratio of soluble to full length CTLA4 mRNA levels with genotype at this variant (17). Interestingly, the fusion protein, Abatacept (Orencia), a biologic drug with proven efficacy in RA, is a CTLA-4 analogue, highlighting the fact that relatively modest genetic effects may identify targets for treatment which are highly effective in large numbers of patients (18).
###end p 25
###begin p 26
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2</italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL21</italic>
A region on chromosome 4q27 also showed evidence for association with RA susceptibility in our UK series. The region exhibits substantial linkage disequilibrium encompassing both the IL2 and IL21 genes. Since both are good candidates as autoimmunity susceptibility genes, identifying the causal polymorphism to determine exactly how it predisposes to autoimmune diseases will be challenging.
###end p 26
###begin p 27
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7R</italic>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C19">19</xref>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
It is interesting to note that the IL7R gene showed a trend towards association with RA. The rs6897932 SNP is located in exon 6 and is associated with increased exon skipping resulting in an alteration in the ratio of the membrane-bound to soluble receptor. The IL7 pathway is important in T cell growth and plays a role in regulating cytokine production and, interestingly, expression of IL7R has been correlated with disease activity in peripheral blood mononuclear cells from patients with RA (19). However, association in other RA data sets is required before this locus can be confidently confirmed as an RA susceptibility gene.
###end p 27
###begin p 28
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2-21</italic>
###xml 321 354 321 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DRB1, PTPN22, STAT4, TRAF1/C5</italic>
###xml 360 367 360 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, IL2RB</italic>
###xml 381 400 381 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, CD40, MMEL1, AFF3</italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 466 474 466 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF1/C5</italic>
In summary, by targeting loci with prior evidence for association with T1D, we have identified a novel association of AFF3 with RA susceptibility. We have also confirmed association of RA with two other loci (CTLA4 and IL2-21/4q27) so that a total of 13 loci have now been confirmed as associated with RA susceptibility (HLA DRB1, PTPN22, STAT4, TRAF1/C5, 6q23, IL2RB, 12q13, 10p15, CD40, MMEL1, AFF3, 4q27 and CTLA-4). Interestingly, for all but one of these loci (TRAF1/C5), association with other autoimmune diseases, including systemic lupus erythematosus, Graves disease and coeliac disease, has been described, firmly establishing the concept of common susceptibility loci for autoimmunity.
###end p 28
###begin title 29
MATERIALS AND METHODS
###end title 29
###begin title 30
Sample collections
###end title 30
###begin p 31
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C2">2</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C20">20</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C21">21</xref>
###xml 673 674 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 943 944 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C20">20</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C21">21</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 767 779 <span type="species:ncbi:9606">participants</span>
###xml 926 933 <span type="species:ncbi:9606">patient</span>
###xml 1047 1055 <span type="species:ncbi:9606">patients</span>
###xml 1165 1173 <span type="species:ncbi:9606">patients</span>
###xml 1306 1314 <span type="species:ncbi:9606">patients</span>
Patients with RA (n = 3,962) were recruited from six centres (Manchester, Sheffield, Leeds, Aberdeen, Oxford and London) across the UK as described previously (2). All cases were Caucasian of Northern European descent and all fulfilled the 1987 American College of Rheumatology classification criteria modified for genetic studies (20,21). Clinical and demographic characteristics of the cohort are detailed in . Briefly, 72% subjects were female, 72% were rheumatoid factor positive and 68% carried ACPA antibodies as recognized by the anti-CCP antibody test. Therefore, this cohort is representative of a hospital-based series of RA subjects. Healthy Caucasian controls (n = 3531) were recruited from five of the six centres (cases only recruited from London). All participants were recruited after providing informed consent and the study was approved by the North West Research Ethics Committee (MREC 99/8/84). Additional patient samples (n = 997) from subjects satisfying ACR criteria for RA (20,21) were obtained from an inception cohort of patients with inflammatory polyarthritis recruited from the Norfolk Arthritis Register (NOAR). Sixty-eight percent of patients were female, 39% were RF positive at baseline and 52% had developed erosions by 5 years. Local Ethics approval was obtained and all patients provided informed consent (LREC 2003-075).
###end p 31
###begin title 32
Immunogenetics
###end title 32
###begin p 33
###xml 424 425 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 214 222 <span type="species:ncbi:9606">Patients</span>
Serum RF and anti-CCP antibody titre were measured using commercially available kits [RF-PAIA Immunoturbidimetric Assay for rheumatoid factor, Diastattrade mark Anti-CCP Kit (Axis-Shield Diagnostics Limited, UK)]. Patients with titres >/=40 units/ml and >/=5 units/ml were defined as positive for RF and anti-CCP antibodies, respectively. Anti-CCP status was available only for a subset of the total validation case cohort (n = 2370).
###end p 33
###begin title 34
Genotyping
###end title 34
###begin p 35
###xml 60 76 60 76 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="www.sequenom.com">www.sequenom.com</uri>
###xml 160 163 160 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arc</bold>
Genotyping was performed using the Sequenom iPlex platform (www.sequenom.com) according to the manufacturer's instructions. All genotyping was performed at the arc Epidemiology Unit, Manchester. Details of the primer and probe sequences used for the SNPs are available on request. Only samples and SNPs exceeding a 90% success rate were used in the analysis.
###end p 35
###begin title 36
Analysis
###end title 36
###begin p 37
###xml 86 87 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 104 106 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C22">22</xref>
###xml 147 148 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 329 372 327 370 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.sph.umich.edu/csg/abecasis/cats/">http://www.sph.umich.edu/csg/abecasis/cats/</uri>
###xml 618 622 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AFF3</italic>
###xml 995 997 988 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</sub>
###xml 1208 1209 1201 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP177C1">1</xref>
###xml 367 371 <span type="species:ncbi:9685">cats</span>
Genotype counts in cases and controls were analysed using PLINK software using the chi2 test for trend (22). A corrected significance threshold of P < 0.004 was selected based on a Bonferroni correction for 14 independent loci tested as part of this study. Power calculations were performed using the CaTS power calculator tool (http://www.sph.umich.edu/csg/abecasis/cats/). Stratification analysis was performed by subgrouping the cases into anti-CCP antibody positive and negative subgroups for comparison with the controls. Stepwise logistic regression was used to determine whether the association observed at the AFF3 locus was primarily due to linkage disequilibrium between the associated SNPs or whether independent effects existed. The possibility of population stratification was not examined because genome-wide data was only available for the WTCCC data set. However, in that cohort, no evidence for global population stratification in the UK population tested was identified (lambdaGC = 1.03 for RA samples versus controls) and allele frequencies in the two other UK control cohorts examined as part of the current study did not differ from the control cohort tested as part of the WTCCC study (1).
###end p 37
###begin title 38
SUPPLEMENTARY MATERIAL
###end title 38
###begin p 39
.
###end p 39
###begin title 40
[Supplementary Data]
###end title 40
###begin title 41
FUNDING
###end title 41
###begin p 42
###xml 84 89 84 89 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17552</grant-num>
###xml 129 180 129 180 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NHS Research and Development Support Fund for Guy&#8217;s</grant-sponsor>
###xml 185 219 185 219 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">St Thomas&#8217; and Lewisham NHS Trusts</grant-sponsor>
###xml 260 296 260 296 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">British 1958 Birth Cohort collection</grant-sponsor>
###xml 312 336 312 336 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Medical Research Council</grant-sponsor>
###xml 343 351 343 351 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0000934</grant-num>
###xml 360 374 360 374 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wellcome Trust</grant-sponsor>
###xml 381 392 381 392 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">068545/Z/02</grant-num>
We thank the Arthritis Research Campaign for their support. arc grant reference no. 17552. We would also like to acknowledge the NHS Research and Development Support Fund for Guy's and St Thomas' and Lewisham NHS Trusts. We acknowledge the use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Funding to pay the Open Access charge was provided by the Arthritis Research Campaign.
###end p 42
###begin title 43
ACKNOWLEDGEMENTS
###end title 43
###begin p 44
###xml 13 28 13 28 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YEAR consortium</grant-sponsor>
We thank the YEAR consortium for allowing us access to their DNA collection. IT support was provided by Phil Steer and technical support by Paul Gilbert, Bhaneeta Lad and Stephen G Martin. Nursing support was provided by Janet Grumley, Julie Shotton and Claire Farrar. We acknowledge support from the EU FP6 programme AutoCure and the Manchester Biomedical Research Centre.
###end p 44
###begin p 45
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement: None declared.
###end p 45
###begin title 46
REFERENCES
###end title 46
###begin article-title 47
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 47
###begin article-title 48
Rheumatoid arthritis association at 6q23
###end article-title 48
###begin article-title 49
TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study
###end article-title 49
###begin article-title 50
Two independent alleles at 6q23 associated with risk of rheumatoid arthritis
###end article-title 50
###begin article-title 51
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
###end article-title 51
###begin article-title 52
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13
###end article-title 52
###begin article-title 53
Autoimmune diseases co-occurring within individuals and within families: a systematic review
###end article-title 53
###begin article-title 54
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
###end article-title 54
###begin article-title 55
Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases
###end article-title 55
###begin article-title 56
Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis
###end article-title 56
###begin article-title 57
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4 and PADI4
###end article-title 57
###begin article-title 58
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis
###end article-title 58
###begin article-title 59
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis
###end article-title 59
###begin article-title 60
Shared and distinct genetic variants in type 1 diabetes and celiac disease
###end article-title 60
###begin article-title 61
The expanding genetic overlap between multiple sclerosis and type I diabetes
###end article-title 61
###begin article-title 62
LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias
###end article-title 62
###begin article-title 63
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
###end article-title 63
###begin article-title 64
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
###end article-title 64
###begin article-title 65
Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate
###end article-title 65
###begin article-title 66
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
###end article-title 66
###begin article-title 67
A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results from an analysis from a nationwide twin study
###end article-title 67
###begin article-title 68
PLINK: a tool set for whole-genome association and population-based linkage analyses
###end article-title 68

